Skip to main content
Livermore
Livermore
ZHEN

Simplex Trading, LLC

SEC CIK
0001488542
Latest filing
Aug 12, 2026

GALT holding history

Galectin Therapeutics Inc in every 13F filed by Simplex Trading, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GALT overviewAll 13F holders of GALTFull Q2 2026 holdings

Shares (Q2 2026)
83,251
Value
$386.3K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of GALT by Simplex Trading, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202683,251$386.3K<0.1%−749−0.9%ReducedHolders
Q1 202684,000$234.4K<0.1%+78,421+1,405.6%AddedHolders
Q4 20255,579$23.2K<0.1%−61,761−91.7%ReducedHolders
Q3 202567,340$285.0K<0.1%+22,646+50.7%AddedHolders
Q2 202544,694$94.0K<0.1%+43,915+5,637.4%AddedHolders
Q1 2025779$00.0%−17,205−95.7%ReducedHolders
Q4 202417,984$23.0K<0.1%+8,194+83.7%AddedHolders
Q3 20249,790$26.0K<0.1%−1,564−13.8%ReducedHolders
Q2 202411,354$25.0K<0.1%+3,477+44.1%AddedHolders
Q1 20247,877$18.0K<0.1%+917+13.2%AddedHolders
Q4 20236,960$11.0K<0.1%−3,737−34.9%ReducedHolders
Q3 202310,697$20.0K<0.1%+1,883+21.4%AddedHolders
Q2 20238,814$12.0K<0.1%+817+10.2%AddedHolders
Q1 20237,997$16.0K<0.1%−11,726−59.5%ReducedHolders
Q4 202219,723$22.0K<0.1%+9,293+89.1%AddedHolders
Q3 202210,430$17.0K<0.1%−17,441−62.6%ReducedHolders
Q2 202227,871$36.0K<0.1%+14,930+115.4%AddedHolders
Q1 202212,941$20.0K<0.1%+8,635+200.5%AddedHolders
Q4 20214,306$8.00K<0.1%+4,306NewHolders
Q2 20210$00.0%−3,910−100.0%Sold outHolders
Q1 20213,910$8.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.